Literature DB >> 30697436

Hemobilia from arteriobiliary fistula.

Puneet Menaria1, Venkata Muddana2.   

Abstract

Entities:  

Year:  2019        PMID: 30697436      PMCID: PMC6345089          DOI: 10.1093/omcr/omy120

Source DB:  PubMed          Journal:  Oxf Med Case Reports        ISSN: 2053-8855


× No keyword cloud information.

CASE DESCRIPTION

A 59-year-old female presented to hospital with hematemesis, she had a history of autoimmune hepatitis requiring liver transplant complicated by hepatic artery thrombosis requiring vascular interventions. Post-transplant she developed intrahepatic duct ischemic strictures and underwent multiple endoscopic retrograde cholangiopancreatography (ERCP) interventions with balloon dilations and stent placements. Her biliary strictures improved and subsequently all the stents were removed. There were no immediate complications following the ERCP with no evidence of fistulous connection on fluoroscopy image(Fig. 1). Few months later, she presented to hospital multiple times with hematemesis and melena requiring blood transfusions. Endoscopic work up was unrevealing, pillcam deployment and antegrade double balloon enteroscopy could not identify an obvious source to explain the large GI bleeding. Eventually on one of the episodes of large volume hematemesis with hypotension requiring large volume transfusion and intubation; on upper endoscopy active hemobilia was visualized (Fig. 2).
Figure 1:

ERCP image: post stents with no fistulous connection.

Figure 2:

Hemobilia: endoscopic image of active bleeding from ampulla.

ERCP image: post stents with no fistulous connection. Hemobilia: endoscopic image of active bleeding from ampulla. An emergent catheter guided mesenteric angiogram noted Ateriobiliary fistula between R hepatic artery and common hepatic duct (Fig. 3), transcatheter coil/Gelfoam slurry embolization of the right hepatic artery was done (Fig. 4). Post-embolization angiogram shows closure of fistula (Fig. 5), hematemesis resolved following the procedure.
Figure 3:

Areteriobiliary fistula: fistula between R hepatic artery and common hepatic duct.

Figure 4:

Angio intervention: attempted closure of ateriobiliary fistula.

Figure 5:

Post coil: successful closure of fistula with no arterial contrast flow into common hepatic duct.

Areteriobiliary fistula: fistula between R hepatic artery and common hepatic duct. Angio intervention: attempted closure of ateriobiliary fistula. Post coil: successful closure of fistula with no arterial contrast flow into common hepatic duct.

DISCUSSION

Hemobilia is defined as the presence of blood in the biliary tree. Presentation is with signs and symptoms of an upper GI bleed. Hemobilia is often missed due to the low frequency encountered in clinical practice and at times because of the intermittent nature of bleeding. Hemobilia can potentially cause life-threatening bleeding as in the case described. Pathology happens due to development of a fistulous connection between hepatic vasculature and biliary system. With the increase in number of hepatobiliary procedures most cases reported now are iatrogenic, other known causes include liver trauma as well as hepatic tumors [1]. Case series from Nicholson et al reported GI bleeding from R hepatic artery injury in 0.6% of patients undergoing laparoscopic cholecystectomy; though a small percentage it amounts to a large absolute number given the high frequency of laparoscopic cholecytectomy[2]. Upper GI bleeding with history of recent or previous interventions to liver (parenchyma or vessels) or biliary tree shall raise a suspicion of hemobilia. Timely performed upper GI endoscopy can establish the diagnosis with identification of passage of blood from the duodenal papilla or presence of a clot occluding the papilla. Success rate in identification of hemobilia with endoscopy have been variable; one small case series have reported a positive identification rate of 60% [3]. Non-diagnostic endoscopy in clinicaly stable patients shall be evaluated with CT angiography (CTA). This allows for identification of direct (passage of contrast into biliary tree) or indirect evidence of blood in biliary tree.CTA is also helpful in planning angiographic intervention by assessing vascular anatomy especially in cases with prior history of surgery or in recipients of liver transplant. Magnetic resonance cholangiopancreatography can also well establish the presence of blood in biliary tree however does not allow for evaluation of blood vessels and is time consuming. Immediate catheter-based angiography is indicated if endoscopy confirms hemobilia and/or in patients with hemodynamic instability, Angiography offers not only a diagnostic but also therapeutic options to control bleeding with coil embolization, thrombin injection or stent placement [1]. In addition, ERCP may be needed to clear the biliary obstruction from clotted blood in biliary tree.

Author Contribution

Each person listed as an author has participated in the creation of this manuscript including drafting of the article and critical revision of the article for important intellectual content.
  3 in total

1.  Massive hemobilia: a diagnostic and therapeutic challenge.

Authors:  Satish Devakumar Murugesan; Jeswanth Sathyanesan; Anand Lakshmanan; Sukumar Ramaswami; Senthilkumar Perumal; Srinivasan Ulagendra Perumal; Ravi Ramasamy; Ravichandran Palaniappan
Journal:  World J Surg       Date:  2014-07       Impact factor: 3.352

Review 2.  Hemobilia.

Authors:  Rakesh Navuluri
Journal:  Semin Intervent Radiol       Date:  2016-12       Impact factor: 1.513

3.  Hepatic artery angiography and embolization for hemobilia following laparoscopic cholecystectomy.

Authors:  T Nicholson; S Travis; D Ettles; J Dyet; P Sedman; K Wedgewood; C Royston
Journal:  Cardiovasc Intervent Radiol       Date:  1999-01       Impact factor: 2.740

  3 in total
  1 in total

1.  Spontaneous Arteriocholedochal Fistula as a Cause of Life-Threatening Hemobilia in a Type I Giant Choledochal Cyst: A Case Report on an Unusual Situation Requiring Whipple's Pancreatoduodenectomy.

Authors:  Humaid Ahmad; Madiha K Bajwa; Irfan Lutfi; Jahanzaib Haider; Shams Nadeem Alam
Journal:  Cureus       Date:  2019-08-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.